Publications of Daniel Rüdiger
All genres
Journal Article (4)
1.
Journal Article
27 (4), 109421 (2024)
Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 2.
Journal Article
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 3.
Journal Article
17, e1009357 (2021)
Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture. PLoS Computational Biology 4.
Journal Article
15 (2), e1006819 (2019)
Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions. PLoS Computational Biology Conference Paper (1)
5.
Conference Paper
51 (19), pp. 32 - 33 (2018)
A multiscale model of influenza A virus replication covering highly different infection conditions in cell cultures. IFAC-PapersOnLine Talk (17)
6.
Talk
Engineered defective interfering particles of influenza A virus for antiviral treatment. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
7.
Talk
Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)
8.
Talk
A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systems. 28th ESACT Meeting, Edingburgh (Scotland) (2024)
9.
Talk
Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissues. KSMB-SMB 2024, Seoul (South Korea) (2024)
10.
Talk
Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. Vir-AI-DIP Workshop , Hamburg (Germany) (2023)
11.
Talk
Absolute quantification of influenza A virus proteins during single-round replication in different host cells. 6th Workshop on Virus Dynamics, Nagoya (Japan) (2023)
12.
Talk
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
13.
Talk
OP7, a defective interfering particle with mutations: in vitro infection experiments, intracellular model, impact of mutations and mode of antiviral action. 6th Workshop on Virus Dynamics, Nagoya (japan) (2023)
14.
Talk
Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
15.
Talk
Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral Candidates. Vaccine Technology VIII, Sitges (Spain) (2022)
16.
Talk
Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidates. 27th ESACT Meeting, Lisbon (Portugal) (2022)
17.
Talk
Modeling the intracellular replication of a new type of defective interfering particle of influenza virus with genomic nucleotide substitutions. 12th European Conference on Mathematical and Theoretical Biology, Heidelberg (Germany) (2022)
18.
Talk
Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. 5th Workshop on Virus Dynamics, virtual (2021)
19.
Talk
Evolution and selection of influenza a virus defective interfering particles in a semi-continuous production system for the use as antiviral. The seventh ESWI Influenza Conference, Virtual Meeting (2020)
20.
Talk
Multiscale model of DIP replication and its effects on influenza A virus infection in animal cell culture. Society for Mathematical Biology 2020 Annual Meeting, Virtual Meeting (2020)